Post-Conference Perspectives: Understanding HER2-Low Breast Cancer - Episode 1

Current Landscape of HER2 Testing in Breast Cancer

,

Shared insight on the current state of HER2 classification and testing and in breast cancer, with respect to how it may influence future treatment approaches.

Now Viewing
EP. 1: Current Landscape of HER2 Testing in Breast Cancer
EP. 2: Strategies in Identifying and Stratifying HER2 Status in Breast Cancer
EP. 3: Treating HER2-low Breast Cancer With Novel Antibody Drug Conjugates
EP. 4: HER2-low Breast Cancer: Practical Applications of ADC Therapy

Related Content:

Post-Conference Perspectives: Understanding HER2-Low Breast CancerBreast Cancer
Pelareorep Plus Chemo Improves OS in Endocrine-Refractory HR+/HER2– Advanced Breast Cancer
Elacestrant Plus Abemaciclib Demonstrates Clinical Benefit in Pretreated ER+/HER2– Metastatic Breast Cancer
Role of Multidisciplinary Team in the Management of Patients Receiving ADCs in Breast Cancer